Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

BioMatrix Specialty Pharmacy Expands Expertise In Oncology And Rare And Ultra-Rare Diseases

Friday, June 28, 2019

BioMatrix Specialty Pharmacy announced today its newest pharmacy location BioMatrix of Maryland significantly expanding its capabilities in oncology and rare and ultrarare diseases The Maryland location is an accredited fullservice specialty pharmacy...

Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-810, for Treatment of Ornithine Transcarbamylase (OTC) Deficiency

Friday, June 28, 2019

Arcturus Therapeutics Holdings Inc a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare liver and respiratory diseases with significant unmet medical need today announced the US Food and Drug A...

Hilleman Laboratories licenses Oral Cholera Vaccine Hillchol® to Bharat Biotech

Friday, June 28, 2019

Hilleman Laboratories a global research and development organization focused on delivering highimpact and affordable vaccines announced today that it has entered into a collaboration with Bharat Biotech International Ltd BBIL a leading vaccine and bi...

New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications

Thursday, June 27, 2019

Sartorius Stedim Biotech SSB a leading international partner of the biopharmaceutical industry today launched a new vessel for its ambr modular benchtop automated mini bioreactor system The singleuse vessel has been specially designed for therapeuti...

Essity integrates BSN medical India into Essity organization

Thursday, June 27, 2019

Leading global health and hygiene company Essity announced the final step in integrating BSN medical India into the Essity organization Following the global acquisition of BSN medical in April the business in India continues its journey as Essity In...

Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency

Thursday, June 27, 2019

Translate Bio a clinicalstage messenger RNA mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction today announced that it has received clearance from the US Fo...

Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors

Thursday, June 27, 2019

Yisheng Biopharma Co Ltd a biopharmaceutical company focusing on research development manufacturing sales and marketing of immunological biologics and vaccines announced that it has received Investigational New Drug IND clearance from the National Me...

Singapore's Drug Development Efforts Given Additional Momentum with National Platforms

Wednesday, June 26, 2019

The nations drug development efforts have been given additional momentum with the introduction of two new platforms and a grant scheme for drug discovery and development These national platforms aim to bridge the valley of death between basic scienc...

Sound Pharmaceuticals announces positive topline results from the SPI-1005 Phase 2b Meniere's Disease clinical trial

Wednesday, June 26, 2019

Sound Pharmaceuticals today announced positive topline results from a randomized doubleblind placebocontrolled multicenter Phase b study in Menieres Disease MD The study consented adult patients with active MD including a hearing loss at baseline of...

WindMIL Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 2 Study of Marrow Infiltrating Lymphocytes (MILs™) in Non-Small Cell Lung Cancer

Wednesday, June 26, 2019

WindMIL Therapeutics a clinicalstage company developing marrowinfiltrating lymphocytes MILs for cancer immunotherapy announced today that it has been cleared by the US Food and Drug Administration FDA to proceed with its Phase study of MILs as a pot...